- Home
- NKSH vs SCPH Comparison
NKSH vs SCPH Comparison
Compare NKSH & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKSH
- SCPH
- Stock Information
- Founded
- NKSH 1891
- SCPH 2013
- Country
- NKSH United States
- SCPH United States
- Employees
- NKSH N/A
- SCPH N/A
- Industry
- NKSH Major Banks
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- NKSH Finance
- SCPH Health Care
- Exchange
- NKSH Nasdaq
- SCPH Nasdaq
- Market Cap
- NKSH 180.8M
- SCPH 179.6M
- IPO Year
- NKSH N/A
- SCPH 2017
- Fundamental
- Price
- NKSH $29.35
- SCPH $3.39
- Analyst Decision
- NKSH Strong Buy
- SCPH Strong Buy
- Analyst Count
- NKSH 1
- SCPH 2
- Target Price
- NKSH $38.00
- SCPH $15.00
- AVG Volume (30 Days)
- NKSH 13.8K
- SCPH 429.4K
- Earning Date
- NKSH 10-24-2024
- SCPH 11-13-2024
- Dividend Yield
- NKSH 5.42%
- SCPH N/A
- EPS Growth
- NKSH N/A
- SCPH N/A
- EPS
- NKSH 1.44
- SCPH N/A
- Revenue
- NKSH $43,450,000.00
- SCPH $30,278,000.00
- Revenue This Year
- NKSH N/A
- SCPH $172.64
- Revenue Next Year
- NKSH $19.72
- SCPH $131.43
- P/E Ratio
- NKSH $19.30
- SCPH N/A
- Revenue Growth
- NKSH N/A
- SCPH 303.87
- 52 Week Low
- NKSH $26.00
- SCPH $3.08
- 52 Week High
- NKSH $35.00
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- NKSH 52.95
- SCPH 49.84
- Support Level
- NKSH $26.00
- SCPH $3.27
- Resistance Level
- NKSH $29.66
- SCPH $3.59
- Average True Range (ATR)
- NKSH 0.84
- SCPH 0.18
- MACD
- NKSH 0.18
- SCPH 0.01
- Stochastic Oscillator
- NKSH 94.40
- SCPH 45.83
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.